Overview
Drug discovery company developing entactogen-based medicines derived from MDMA analogs for psychiatric conditions including PTSD and social anxiety. Their pipeline focuses on compounds with refined safety and efficacy profiles.
More in Psychedelics
Latest industry news
ReVision Implant Secures โฌ4 Million to Advance Next-Generation Visual Neuroprosthetics
2026-07-25 ยท Funding
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Advance Neuroscience Therapeutics
2026-07-24 ยท Funding
Science Corp. Launches Prima BCI Implant in Europe, Bringing Vision Restoration to a New Market
2026-07-23 ยท Product
First Able-Bodied Individuals Receive Brain-Computer Implants in Landmark Expansion of BCI Eligibility
2026-07-22 ยท Research
Company details
Category
๐ Psychedelics
Location
San Francisco, CA, USA
Funding
Seed ยท $4M
Website
tactogen.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ